Deal of the Day — limited-time pharmacy picks!
Arbaz 60mg Injection

Arbaz 60mg Injection

Prescription requiredRx Required

Salt Composition: Cabazitaxel

Expiry Date: 01/2028

Special offer

Buy at $139.41

$139.41

Inclusive of all taxes

▼

1 Injection

About The Product

Prostate Cancer

Description

Arbaz 60mg Injection is used to treat advanced prostate cancer in adults, belongs to the group of medicines called antineoplastics. It works by stopping the formation of cancer cells in the body.

The medication contains an active ingredient Cabazitaxel which is primary used to treat hormone-refractory (castration- resistant) prostate cancer. It inhibits microtubule disassembly which prevent cancer cells from dividing and leading to and leads to cell death.

Doctor guidance is required to close monitor the blood counts, liver function and kidney function to ensure safe and effective treatment option.

Indication

Prostate cancer

Common Side Effects

● Anemia
● Low white blood cell count
● Low platelet count
● Fatigue and nausea
● Loose or watery stools
● Blood in urine
● Breathing problems
● Weakness
● Back pain
● Hair loss

Dosage And Duration

  • Arbaz 60mg Injection is an anticancer medication which should be taken on 60mg Injection with food at the fixed time everyday.
  • Taking it in the wrong way or taking too much may cause serious side effects, consult with the doctor for proper dosage and duration of the medication.
  • It may take several weeks or months to get most benefit but consistency is key.

Mechanism Of Action

Prostate gland is a part of the male reproductive system, located below the bladder in the pelvic region of abdomen. It produces the fluid called seminal fluid that nourishes and transports sperm in males.

Arbaz 60mg Injection blocks the pathway of microtubule disassembly in cancer cells, preventing their division and growth, thereby inhibiting the progression of prostate cancer.

Safety Advice

Alcohol
Alcohol is prohibited while taking Arbaz 60mg Injection as it cause unwanted side effects and make complications during the treatment.
Driving
Arbaz 60mg Injection may decrease alertness and affect the vision make you feel sleepy and dizzy but it is better to consult the doctor first.
Pregnancy
Pregnant women should avoid using Arbaz 60mg Injection as the medicine can cause harm to the baby.
Breast Feeding
Women are taking Arbaz 60mg Injection should avoid feeding milk to their baby, as it affects on breast milk and may cause serious risk to the baby.
Kidney
Arbaz 60mg Injection is not recommended to kidney patients as body may not handle the drug effectively.
Liver
Patient with liver disease must recommended the correct dose of Arbaz 60mg Injection, the medication should affect liver function and improper dosing may lead to severe liver related complications.

Faqs

Arbaz 60mg Injection can be taken by advanced stage of prostate cancer by blocking the enzyme causing cancer cells and prevent the body from further growing cancer in the body.

References

• Omer, A. B., Altayb, H.

N., Al-Abbasi, F. A., Gupta, G., Ahmed, M.

M., Alghamdi, A. M., ... & Kazmi, I.

(2023). Acemannan ameliorates STZ-activated diabetes by attenuating high glucose via inhibiting inflammatory cytokines and apoptosis pathway.

International Journal of Biological Macromolecules, 253, 127127. • Saifi, M. A., Shaikh, A.

S., Kaki, V. R., & Godugu, C.

(2022). Disulfiram prevents collagen crosslinking and inhibits renal fibrosis by inhibiting lysyl oxidase enzymes.

Journal of Cellular Physiology, 237(5), 2516-2527. • Schaller, G., Kolodjaschna, J., Pleiner, J., Mittermayer, F., Kapiotis, S., Schmetterer, L., & Wolzt, M. (2008).

Pioglitazone does not affect vascular or inflammatory responses after endotoxemia in humans. Hormone and metabolic research, 40(08), 549-555. • Luksch, A., Rainer, G., Koyuncu, D., Ehrlich, P., Maca, T., Gschwandtner, M.

E., ... & Schmetterer, L. (2005).

Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma. British journal of ophthalmology, 89(1), 21-25. • Ahmad, A.

O., Mohanty, P. K., & Yadav, P.

K. (2024).

Review on Epcoritamab: A New FDA-Approved Medicine for Adult Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma. International Journal of Research in Pharmacy and Allied Science, 3(1), 91-103.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026